Distinguished in Angiosarcoma

Dr. Reshma L. Mahtani

Oncology | Hematology Oncology | Hematology
Baptist Health Medical Group Oncology LLC
8900 N Kendall Dr, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Distinguished in Angiosarcoma
Baptist Health Medical Group Oncology LLC
8900 N Kendall Dr, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Reshma Mahtani is an Oncologist and a Hematologist Oncology provider in Miami, Florida. Dr. Mahtani is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Febrile Neutropenia, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Mahtani is currently accepting new patients.

Her clinical research consists of co-authoring 53 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology Oncology
Hematology
Licenses
Internal Medicine in FL
Hospital Affiliations
South Miami Hospital
Baptist Hospital Of Miami
Languages Spoken
English
Hindi
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

BAPTIST HEALTH MEDICAL GROUP ONCOLOGY LLC
8900 N Kendall Dr, Miami, FL 33176

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2024
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Phase II Study of Neratinib Alone and in Combination With Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
A Phase II Study of Neratinib Alone and in Combination With Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Enrollment Status: Completed
Publish Date: April 15, 2022
Intervention Type: Procedure, Drug
Study Phase: Phase 2
A Phase I/II Study to Evaluate the Safety and Efficacy of Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
A Phase I/II Study to Evaluate the Safety and Efficacy of Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: April 17, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
Enrollment Status: Completed
Publish Date: June 27, 2018
View 4 Less Clinical Trials

53 Total Publications

Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.
Journal: Journal of neuro-oncology
Published: July 31, 2025
Similar Doctors
Distinguished in Angiosarcoma
Dr. Grace Wang
Hematology Oncology | Hematology | Oncology
Distinguished in Angiosarcoma
Dr. Grace Wang
Hematology Oncology | Hematology | Oncology

Baptist Health Medical Group Oncology LLC

8900 N Kendall Dr, 
Miami, FL 
 (0.1 miles away)
786-596-2000
Languages Spoken:
English, German, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Grace Wang is a Hematologist Oncology specialist and a Hematologist in Miami, Florida. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Wang is currently accepting new patients.

Distinguished in Angiosarcoma
Dr. Elisa A. Krill-Jackson
Hematology Oncology | Oncology | Hematology
Distinguished in Angiosarcoma
Dr. Elisa A. Krill-Jackson
Hematology Oncology | Oncology | Hematology

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (10.9 miles away)
Languages Spoken:
English, Italian, Louisiana Creole French, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Elisa Krill-Jackson is a Hematologist Oncology specialist and an Oncologist in Miami, Florida. Dr. Krill-Jackson is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Krill-Jackson is currently accepting new patients.

Distinguished in Angiosarcoma
Dr. Sara M. Garrido
Hematology Oncology | Hematology | Oncology
Distinguished in Angiosarcoma
Dr. Sara M. Garrido
Hematology Oncology | Hematology | Oncology

Baptist Health Medical Group Oncology LLC

9555 Sw 162 Ave, 
Miami, FL 
 (7.2 miles away)
786-467-2000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sara Garrido is a Hematologist Oncology specialist and a Hematologist in Miami, Florida. Dr. Garrido is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Garrido is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mahtani's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile